 | Up a level |
Tamargo, J; Kjeldsen, K P; Delpón, E; Semb, A G; Cerbai, E; Dobrev, D; Savarese, G; Sulzgruber, P; Rosano, G; Borghi, C; Wassman, S; Torp-Pedersen, C T; Agewall, S; Drexel, H; Baumgartner, I; Lewis, B S; Ceconi, C; Kaski, J C; Niessner, A (2022). Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European heart journal. Cardiovascular pharmacotherapy, 8(4), pp. 406-419. Oxford University Press 10.1093/ehjcvp/pvac005
Kleber, M E; Goliasch, G; Grammer, T B; Pilz, S; Tomaschitz, A; Silbernagel, Günther; Maurer, G; März, W; Niessner, A (2014). Evolving biomarkers improve prediction of long-term mortality in patients with stable coronary artery disease: the BIO-VILCAD score. Journal of internal medicine, 276(2), pp. 184-194. Blackwell Scientific Publications 10.1111/joim.12189
Koller, L; Kleber, M; Goliasch, G; Sulzgruber, P; Scharnagl, H; Silbernagel, Günther; Grammer, T; Delgado, G; Tomaschitz, A; Pilz, S; März, W; Niessner, A (2014). C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction. European journal of heart failure, 16(7), pp. 758-766. Oxford University Press 10.1002/ejhf.104
